SS-31 (Elamipretide)

Mitochondrial & MetabolicResearch Use Only

Also known as: Elamipretide, MTP-131, Bendavia, SS-31

SS-31, also known as elamipretide, is a mitochondria-targeting peptide commonly referenced in cellular-energy research literature. Studies describe its association with the inner mitochondrial membrane lipid cardiolipin and its role in supporting mitochondrial function. It has been investigated in various preclinical and clinical research settings.

Typical range (research)

Research literature references vary; clinical studies have explored amounts in roughly the ~10–40 mg/day range

Half-life

Short (reported in clinical pharmacokinetic data)

Route

Subcutaneous (research)

Common use

Mitochondrial function research

Common vial sizes

10 mg · 30 mg · 50 mg

Storage

Store lyophilized powder refrigerated (2–8°C) and protected from light; once reconstituted, keep refrigerated and use within the timeframe supported by stability data.

Stacking notes

Sometimes referenced alongside other mitochondrial compounds such as MOTS-C or NAD+ in research discussions; combinations are not well characterized.

Reported side effects

Injection-site reactions (reported)Generally reported as well tolerated in trials

Regulatory note: Investigational; not approved as a therapeutic drug in Canada or the US. Studied in clinical trials for mitochondrial conditions. Research-grade material is not for human use.

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.